Search Results

Filter
  • 1-10 of  500 results for ""Oxidopamine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Nucleus of the solitary tract neuronal degeneration and impaired hypoxia response in a model of Parkinson's disease.

  • Authors : Naccarato MC; Department of Pharmacology, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, SP, 05508 Sao Paulo, SP, Brazil.; Oliveira LM

Subjects: Rats, Wistar* ; Solitary Nucleus*/Solitary Nucleus*/Solitary Nucleus*/pathology ; Hypoxia*/Hypoxia*/Hypoxia*/pathology

  • Source: Experimental neurology [Exp Neurol] 2024 Oct; Vol. 380, pp. 114924. Date of Electronic Publication: 2024 Aug 13.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Upregulation of Nav1.6 expression in the ventral posterolateral nucleus of thalamus contributes to hyperalgesia in a model of Parkinson's disease.

  • Authors : Li Z; School of Life Science, Shanghai University, China.; Luo J

Subjects: Hyperalgesia*/Hyperalgesia*/Hyperalgesia*/metabolism ; NAV1.6 Voltage-Gated Sodium Channel*/NAV1.6 Voltage-Gated Sodium Channel*/NAV1.6 Voltage-Gated Sodium Channel*/metabolism ; NAV1.6 Voltage-Gated Sodium Channel*/NAV1.6 Voltage-Gated Sodium Channel*/NAV1.6 Voltage-Gated Sodium Channel*/biosynthesis

  • Source: Experimental neurology [Exp Neurol] 2025 Jan; Vol. 383, pp. 115032. Date of Electronic Publication: 2024 Oct 28.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Moderate intensity aerobic exercise alleviates motor deficits in 6-OHDA lesioned rats and reduces serum levels of biomarkers of Parkinson's disease severity without recovery of striatal dopamine or tyrosine hydroxylase.

  • Authors : Kasanga EA; Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, United States of America.; Soto I

Subjects: Tyrosine 3-Monooxygenase*/Tyrosine 3-Monooxygenase*/Tyrosine 3-Monooxygenase*/metabolism ; Oxidopamine*/Oxidopamine*/Oxidopamine*/toxicity ; Corpus Striatum*/Corpus Striatum*/Corpus Striatum*/metabolism

  • Source: Experimental neurology [Exp Neurol] 2024 Sep; Vol. 379, pp. 114875. Date of Electronic Publication: 2024 Jun 27.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

5-HT4R agonism reduces L-DOPA-induced dyskinesia via striatopallidal neurons in unilaterally 6-OHDA lesioned mice.

  • Authors : Ballardin D; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Laboratory of Signaling mechanisms in neurological disorders, 75014 Paris, France.; Makrini-Maleville L

Subjects: Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/drug therapy ; Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/metabolism ; Levodopa*/Levodopa*/Levodopa*/pharmacology

  • Source: Neurobiology of disease [Neurobiol Dis] 2024 Aug; Vol. 198, pp. 106559. Date of Electronic Publication: 2024 Jun 07.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Imaging of cerebral tryptophan metabolism using 7-[ 18 F]FTrp-PET in a unilateral Parkinsonian rat model.

  • Authors : Endepols H; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Radiochemistry and Experimental Molecular Imaging, Kerpener Str. 62, 50937 Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, Kerpener Str. 62, 50937 Cologne, Germany

Subjects: Positron-Emission Tomography*; Oxidopamine/Oxidopamine/Oxidopamine/*metabolism ; Parkinson Disease/Parkinson Disease/Parkinson Disease/*diagnostic imaging

  • Source: NeuroImage [Neuroimage] 2022 Feb 15; Vol. 247, pp. 118842. Date of Electronic Publication: 2021 Dec 21.Publisher: Academic Press Country of Publication: United States NLM ID: 9215515 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

The p75 neurotrophin receptor as a novel intermediate in L-dopa-induced dyskinesia in experimental Parkinson's disease.

  • Authors : Liu Z; Department of Neurology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200082, China.; Yan A

Subjects: Dyskinesia, Drug-Induced/Dyskinesia, Drug-Induced/Dyskinesia, Drug-Induced/*metabolism ; Levodopa/Levodopa/Levodopa/*toxicity ; Nerve Tissue Proteins/Nerve Tissue Proteins/Nerve Tissue Proteins/*biosynthesis

  • Source: Experimental neurology [Exp Neurol] 2021 Aug; Vol. 342, pp. 113740. Date of Electronic Publication: 2021 May 07.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Hydrogen sulfide attenuates induction and prevents progress of the 6-hydroxydopamine-induced Parkinsonism in rat through activation of ATP-sensitive potassium channels and suppression of ER stress.

  • Authors : Minaei A; Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran.; Sarookhani MR

Subjects: Disease Progression*; Endoplasmic Reticulum Stress/Endoplasmic Reticulum Stress/Endoplasmic Reticulum Stress/*drug effects ; Hydrogen Sulfide/Hydrogen Sulfide/Hydrogen Sulfide/*therapeutic use

  • Source: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2021 Jul 15; Vol. 423, pp. 115558. Date of Electronic Publication: 2021 May 04.Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Early decreases in cortical mid-gamma peaks coincide with the onset of motor deficits and precede exaggerated beta build-up in rat models for Parkinson's disease.

  • Authors : Brazhnik E; Neurophysiological Pharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3702, United States of America.; Novikov N

Subjects: Beta Rhythm/Beta Rhythm/Beta Rhythm/*physiology ; Gamma Rhythm/Gamma Rhythm/Gamma Rhythm/*physiology ; Motor Cortex/Motor Cortex/Motor Cortex/*physiopathology

  • Source: Neurobiology of disease [Neurobiol Dis] 2021 Jul; Vol. 155, pp. 105393. Date of Electronic Publication: 2021 May 15.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Unilateral accumbal dopamine depletion affects decision-making in a side-specific manner.

  • Authors : Cunha AM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.

Subjects: Behavior, Animal/Behavior, Animal/Behavior, Animal/*physiology ; Decision Making/Decision Making/Decision Making/*physiology ; Dopaminergic Neurons/Dopaminergic Neurons/Dopaminergic Neurons/*physiology

  • Source: Experimental neurology [Exp Neurol] 2020 May; Vol. 327, pp. 113221. Date of Electronic Publication: 2020 Feb 03.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of K ATP channels, alpha 2 adrenoceptors and anti-inflammatory mechanisms.

  • Authors : Minaei A; Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.; Haghdoost-Yazdi H

Subjects: Dexmedetomidine/Dexmedetomidine/Dexmedetomidine/*therapeutic use ; Inflammation Mediators/Inflammation Mediators/Inflammation Mediators/*metabolism ; KATP Channels/KATP Channels/KATP Channels/*metabolism

  • Source: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2019 Nov 01; Vol. 382, pp. 114743. Date of Electronic Publication: 2019 Aug 30.Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  500 results for ""Oxidopamine""